CN103251748A - 一种治疗过食熏肉型贲门炎的中药制备方法 - Google Patents
一种治疗过食熏肉型贲门炎的中药制备方法 Download PDFInfo
- Publication number
- CN103251748A CN103251748A CN2013101978498A CN201310197849A CN103251748A CN 103251748 A CN103251748 A CN 103251748A CN 2013101978498 A CN2013101978498 A CN 2013101978498A CN 201310197849 A CN201310197849 A CN 201310197849A CN 103251748 A CN103251748 A CN 103251748A
- Authority
- CN
- China
- Prior art keywords
- grams
- herba
- radix
- traditional chinese
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 235000015241 bacon Nutrition 0.000 title claims abstract description 23
- 210000002318 cardia Anatomy 0.000 title claims abstract description 23
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 17
- 230000004054 inflammatory process Effects 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 206010020710 Hyperphagia Diseases 0.000 title abstract 4
- 235000020830 overeating Nutrition 0.000 title abstract 4
- 241000746375 Andrographis Species 0.000 claims abstract description 7
- 239000000796 flavoring agent Substances 0.000 claims description 9
- 235000019634 flavors Nutrition 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 7
- 241001094455 Cipangopaludina chinensis Species 0.000 claims description 6
- 241000756943 Codonopsis Species 0.000 claims description 6
- 239000009806 pulsatillae Substances 0.000 claims description 6
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 3
- 241000209035 Ilex Species 0.000 abstract 2
- 235000003332 Ilex aquifolium Nutrition 0.000 abstract 2
- 235000002296 Ilex sandwicensis Nutrition 0.000 abstract 2
- 235000002294 Ilex volkensiana Nutrition 0.000 abstract 2
- 241001093951 Ailanthus altissima Species 0.000 abstract 1
- 241000512005 Alstonia Species 0.000 abstract 1
- 241000206471 Anemone quinquefolia Species 0.000 abstract 1
- 241000722824 Ardisia crenata Species 0.000 abstract 1
- 241000596154 Belamcanda Species 0.000 abstract 1
- 241001313086 Betula platyphylla Species 0.000 abstract 1
- 235000001553 Betula platyphylla Nutrition 0.000 abstract 1
- 241001195282 Bidens biternata Species 0.000 abstract 1
- 241000233838 Commelina Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 241000218170 Coriaria Species 0.000 abstract 1
- 241000218176 Corydalis Species 0.000 abstract 1
- 244000130270 Fagopyrum tataricum Species 0.000 abstract 1
- 235000014693 Fagopyrum tataricum Nutrition 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000594394 Hedyotis Species 0.000 abstract 1
- 244000130592 Hibiscus syriacus Species 0.000 abstract 1
- 235000018081 Hibiscus syriacus Nutrition 0.000 abstract 1
- 235000017309 Hypericum perforatum Nutrition 0.000 abstract 1
- 244000141009 Hypericum perforatum Species 0.000 abstract 1
- 235000003365 Ilex pubescens Nutrition 0.000 abstract 1
- 241001100932 Ilex pubescens Species 0.000 abstract 1
- 240000006550 Lantana camara Species 0.000 abstract 1
- 241000319062 Lycoris radiata Species 0.000 abstract 1
- 240000007817 Olea europaea Species 0.000 abstract 1
- 244000038594 Phyllanthus urinaria Species 0.000 abstract 1
- 244000233952 Polygonum bistorta Species 0.000 abstract 1
- 235000014258 Polygonum bistorta Nutrition 0.000 abstract 1
- 244000081923 Rumex patientia Species 0.000 abstract 1
- 235000008330 Rumex patientia Nutrition 0.000 abstract 1
- 241000612118 Samolus valerandi Species 0.000 abstract 1
- 241001302210 Sida <water flea> Species 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 abstract 1
- 240000001519 Verbena officinalis Species 0.000 abstract 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 abstract 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 abstract 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 abstract 1
- 241000028204 Vincetoxicum atratum Species 0.000 abstract 1
- 241000534448 Viviparidae Species 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 description 47
- 239000003440 toxic substance Substances 0.000 description 40
- 210000004185 liver Anatomy 0.000 description 39
- 210000002784 stomach Anatomy 0.000 description 35
- 230000001737 promoting effect Effects 0.000 description 32
- 210000004072 lung Anatomy 0.000 description 29
- 208000004880 Polyuria Diseases 0.000 description 27
- 230000035619 diuresis Effects 0.000 description 27
- 210000002216 heart Anatomy 0.000 description 21
- 210000002429 large intestine Anatomy 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 19
- 235000009508 confectionery Nutrition 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 229940079593 drug Drugs 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 16
- 206010020751 Hypersensitivity Diseases 0.000 description 12
- 230000007815 allergy Effects 0.000 description 12
- 206010000087 Abdominal pain upper Diseases 0.000 description 11
- 208000026935 allergic disease Diseases 0.000 description 11
- 230000023597 hemostasis Effects 0.000 description 11
- 206010030113 Oedema Diseases 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 230000001939 inductive effect Effects 0.000 description 9
- 206010010774 Constipation Diseases 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 8
- 208000001647 Renal Insufficiency Diseases 0.000 description 6
- 208000003455 anaphylaxis Diseases 0.000 description 6
- 208000007502 anemia Diseases 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 201000006370 kidney failure Diseases 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010008479 Chest Pain Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 229930182555 Penicillin Natural products 0.000 description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229940049954 penicillin Drugs 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 201000010000 Agranulocytosis Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 206010000269 abscess Diseases 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 206010043554 thrombocytopenia Diseases 0.000 description 4
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- 206010002199 Anaphylactic shock Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010018687 Granulocytopenia Diseases 0.000 description 3
- 208000015817 Infant Nutrition disease Diseases 0.000 description 3
- 208000000112 Myalgia Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 206010041349 Somnolence Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 208000006218 bradycardia Diseases 0.000 description 3
- 230000036471 bradycardia Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000007849 functional defect Effects 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 208000014644 Brain disease Diseases 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 208000032274 Encephalopathy Diseases 0.000 description 2
- 206010053155 Epigastric discomfort Diseases 0.000 description 2
- 206010015218 Erythema multiforme Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 241000736919 Pelodiscus sinensis Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010040007 Sense of oppression Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010042033 Stevens-Johnson syndrome Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000001871 Tachycardia Diseases 0.000 description 2
- 206010044223 Toxic epidermal necrolysis Diseases 0.000 description 2
- 231100000087 Toxic epidermal necrolysis Toxicity 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 201000000079 gynecomastia Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 201000006334 interstitial nephritis Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 208000023482 precordial pain Diseases 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 2
- 230000006794 tachycardia Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000007743 Acute Abdomen Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 206010003671 Atrioventricular Block Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012373 Depressed level of consciousness Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010014950 Eosinophilia Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010056325 Faecaloma Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000001287 Galactorrhea Diseases 0.000 description 1
- 206010017600 Galactorrhoea Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000034308 Grand mal convulsion Diseases 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- 208000029663 Hypophosphatemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 208000010642 Porphyrias Diseases 0.000 description 1
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000008718 Pyuria Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 231100000168 Stevens-Johnson syndrome Toxicity 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940075522 antidotes Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- KZFDVWZZYOPBQZ-UHFFFAOYSA-K bismuth;potassium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].[Bi+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KZFDVWZZYOPBQZ-UHFFFAOYSA-K 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000005098 blood-cerebrospinal fluid barrier Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000004209 confusion Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 206010013395 disorientation Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000019564 dysgeusia Nutrition 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 208000011318 facial edema Diseases 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000001118 melena Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗过食熏肉型贲门炎的中药制备方法,属于中药制备方法技术领域。目前治疗过食熏肉型贲门炎,一般采用西药治疗,其缺点是毒副作用大。该发明的技术方案为:取马桑叶、马鞭草、天荞麦根、无花果、木槿皮、五色梅、牛西西、毛冬青、凤眼草、石蒜、田螺、白薇、白头翁、白花蛇舌草、半枝莲、地丁、朱砂根、连翘、岗梅根、金盏银盘、贯叶连翘、珍珠草、茶叶、穿心莲、桦木皮、鸭跖草、射干、拳参、黄连、黄花母、救必应、象皮木、橄榄和甘草,将以上中药放入水中浸泡,然后文火煎制,过滤去渣煎出的药液即为治疗过食熏肉型贲门炎的中药。它的优点是:制作简单,制成的中药液毒副作用小,疗程短,治愈率高。
Description
技术领域
本发明涉及中药制备方法技术领域,更具体的讲是一种治疗过食熏肉型贲门炎的中药制备方法。
背景技术
目前治疗过食熏肉型贲门炎,一般采用:
1、法莫替丁:①禁忌证:对本药过敏者、严重肾功能不全者、孕妇、哺乳期妇女禁用。②慎用:有药物过敏史、肝、肾功能不全者、婴幼儿应慎用。③可引起便秘、恶心、呕吐、腹泻、腹部不适、口干、食欲不振、腮腺炎及味觉障碍;服药期间,肝脏功能的检测指标可升高;常见头痛,少见的有头晕、意识模糊、焦虑、感觉异常、抑郁、失眠、全身倦怠无力和嗜睡等,少见中性粒细胞减少和血小板减少,嗜酸粒细胞增多,少见性欲降低;少见皮疹、荨麻疹、脱发、痤疮、瘙痒、皮肤干燥和潮红;罕见心悸、心动过缓、房室传导阻滞、血压上升、月经不调,用药期间应监测心电图变化;罕见中毒性表皮坏死溶解;罕见幻觉、癫痫大发作,用药应注意患者临床表现;可致耳鸣;肌肉骨骼疼痛,包括肌肉痛性痉挛和关节痛;可致眶部水肿、面部水肿、结膜充血、血管神经性水肿、药物热、荨麻疹和皮疹等。
2、奥美拉唑:①禁忌证:对本药过敏者、严重肾功能不全者、孕妇、婴幼儿患者禁用。②慎用:肝、肾功能不全者、哺乳期妇女、老年患者应慎用。③常见不良反应是腹泻、头痛、恶心、腹痛、胃肠胀气及便秘,偶见血清氨基转移酶增高、皮疹、眩晕、嗜睡、失眠等;可见胸痛、心悸、心动过速或过缓、血压升高、外周水肿。可见镜下脓尿、蛋白尿、血尿、尿频、泌尿系统感染、间质性肾炎、尿糖、睾丸痛。可见溶血性贫血。可见皮肤潮红、干燥。罕见光敏性、多形性红斑、史-约综合征、毒性上皮坏死溶解、脱发。罕见视物模糊。罕见出汗增多、低钠血症、男子乳腺发育。罕见关节痛、肌痛、肌力减弱。罕见白细胞减少、血小板减少、粒细胞缺乏症和各类血细胞减少。
3、枸橼酸铋钾:①禁忌证:对本药过敏者、严重肾功能不全、孕妇患者禁用。②慎用:肝功能不良者、儿童、哺乳期妇女慎用。③少数患者可有轻微头痛、头晕、失眠等;个别患者可出现皮疹;口中可能带有氨味,且舌、粪便可被染成黑色,易与黑粪症相混淆;个别患者服用时可出现恶心、腹泻、便秘、食欲减退、腹泻等消化道症状。④长期大剂量服用可能引起肾脏毒性,导致可逆性肾衰,并与10日内发作,应定期检查肾功能。⑤骨骼的不良反应较常见的是铋性脑病相关的骨关节病,常以单侧或双肩疼痛为先兆症状。
4、氢氧化铝:①禁忌证:有胆汁、胰液等强碱性消化液分泌不足或排泄障碍者、骨折患者、低磷血症患者及对氢氧化铝过敏者禁用。②慎用:肾功能不全者、长期便秘者、老年人、阑尾炎等急腹症患者慎用。③可引起恶心、呕吐、便秘等症状。长期大量服用,可致严重便秘,甚至粪结块引起肠梗阻。④肾衰竭患者长期服用可引起脑病、痴呆及小细胞性贫血等。
5、西咪替丁:①禁忌证:孕妇、哺乳期妇女禁用。②慎用:严重心脏及呼吸系统疾病、慢性炎症如系统性红斑狼疮(SLE)、器质性脑病、肾功能损害、肝功能不全、幼儿慎用。③较常见的不良反应有腹泻、头晕、乏力、头痛和皮疹等;有用药剂量较大时可引起男性乳房发育、女性溢乳、性欲减退、阳痿、精子计数减少等,可通过血-脑脊液屏障,具有一定的神经毒性。偶见精神紊乱,本品罕见的不良反应有:过敏反应、发热、关节痛、肌痛、粒细胞减少、血小板减少、间质性肾炎、肝脏毒性、心动过缓、心动过速等。
6、雷尼替丁:①禁忌证:对本药及其他H2受体拮抗药过敏者、孕妇、哺乳期妇女、8岁以下儿童禁用。②慎用:肝、肾功能不全者、急性血卟啉症者、老年人慎用。③可出现头痛、头晕、乏力、神志不清、精神行为异常、失眠等;肝、肾功能不全者及老年患者,偶见服药后出现定向力障碍、嗜睡、焦虑等精神症状;有少量发生视力模糊;出现便秘、腹泻、恶心、呕吐、腹痛;可出现皮疹,有极少数发生多形性红斑;罕见关节痛、肌痛;罕见过敏性反应,表现为风疹、血管神经性水肿、发热、支气管痉挛、低血压、过敏性休克、胸痛等;长期使用可致维生素B12缺乏、男性乳房女性化少见;引起肾功能损伤等、静注后部分患者可出现面热感、头晕、恶心、出汗及胃刺激。④本药对肝脏有一定的毒性,故给药过程中,应监测患者肝功能变化。⑤静脉给予本药时,可出现心动过缓。故静注时应缓慢,且用药过程中应定期检查心电图。⑥本药对骨髓有一定的抑制作用,少数患者可发生可逆性中等程度的白细胞或粒细胞减少,也有出现血小板减少以及自身免疫性溶血性贫血。
7、阿莫西林:偶见皮疹,口服大量后可有恶心、上腹部不适、腹泻等;伪膜性结肠炎。
8、羧苄西林:可以出现各种类型的变态反应。大剂量给药后可能引起神经毒反应、肺水肿,用药期间可能出现短暂性转氨酶升高与粒细胞减少。
9、氨苄西林:大量口服常出现胃肠道不适。肌注局部有疼痛。无论口服或注射均可引起变态反应,以皮疹为多见。用药前必须先做皮试。
10、哌拉西林:肌注后偶有局部疼痛,快速静脉推注可导致暂时性恶心、胸闷、咳嗽、发热、口腔异味、眼结膜充血,变态反应(皮疹、痒感、头晕、麻木、发热等),用药前必须注意青霉素有无过敏史,并做青霉素皮试。
11、头孢噻肟:肌注局部可有疼痛;静注时可有血栓性静脉炎发生;皮疹、药物热等变态反应。
12、青霉素:本品易发生变态反应,特别是过敏性休克(最危险的过敏性休克,可发生在做皮肤试验的当时,极少数可发生在连续用药过程中,迟发性过敏性休克),如不及时抢救,可危急生命,故用药前、中、后都要提高防护,以免发生意外。注意:应用前,必须问清有无过敏性疾病,用青霉素后有无皮疹、发热等变态反应出现,务必先做青霉素皮试。
发明内容
为克服上述缺点,本发明的目的是发明一种治疗过食熏肉型贲门炎的中药制备方法。胃分前、后壁。两壁相连处形成两弯,即凸向左下方的胃大弯和凹向右上方的胃小弯,小弯的最低点略凹陷,叫角切迹。胃的入口叫贲门,接食管。胃的出口叫幽门,连十二指肠。幽门的外面有环形的浅沟,内面则突成环状的幽门瓣。贲门炎属于祖国医学“胃痛”的范畴。胃痛,又称胃脘痛,是以上腹胃脘部近心窝处经常发生疼痛为主证。如《素问·六无正纪大论篇》说:“木郁之发,民病胃脘当心而痛。”《灵枢·邪气脏腑病形》篇指出:“胃病者,腹月真胀,胃脘当心而痛。”《外台秘要·心痛方》说:“足阳明为胃之经,气虚逆乘心而痛,其状腹胀归于心而痛甚。谓之胃心痛也。”这里的心痛都是指胃脘痛。在《伤寒论》中所谓的心下痞,按之濡,或心下痞,按之痛等,实皆指胃部而言。古方九种心痛之说,亦多指胃痛而言。《医学正传·胃脘痛》也说:“古方九种心痛,……详其所由。皆在胃脘,而实不在于心也。”寒邪客胃:外感寒邪,内客于胃,寒主收引,致胃气不和而痛。《素问·举痛论篇》说:“寒邪客于肠胃之间,膜原之下,血不得散,小络引急,故痛。”饮食伤胃:饮食不节,或过饥过饱,致胃失和降。《素问·痹论篇》指出:“饮食自倍,肠胃乃伤。”《医学正传·胃脘痛》亦有:“致病之由,多由纵恣口腹,喜好辛酸,恣饮热酒煎复,复餐寒凉生冷,朝伤暮损,日积月深,……故胃脘疼痛”的说法。肝气犯胃:肝为刚脏,性喜条达而主疏泄,若忧思恼怒,则气郁而伤肝,肝木失于疏泄,横逆犯胃,致气机阻滞,因而发生疼痛。如《沈氏尊生书·胃痛》所说:“胃痛,邪干胃脘病也。……唯肝气相乘为尤甚,以木性暴,且正克也。”
病因病机:由于素体热盛,又过食熏肉,损伤于胃,胃的功能失常,而发本病。
临床表现:过食熏肉,咽干、口干、口臭。进食时胃脘疼痛,胸背疼痛,剑突后烧灼感,烧灼感可牵涉至颈、肩胛间区、耳,甚至两上臂,舌质红,苔薄黄,脉数。
它的技术方案为:取三白草6重量份、大青叶5重量份、大金钱草6重量份、山白菊3重量份、山海螺6重量份、千里光6重量份、千金藤6重量份、小飞扬草5重量份、马尾连6重量份、马桑叶4重量份、马鞭草6重量份、天荞麦根6重量份、无花果9重量份、木槿皮6重量份、五色梅5重量份、牛西西6重量份、毛冬青8重量份、凤眼草6重量份、石蒜5重量份、田螺6重量份、白薇3重量份、白头翁4重量份、白花蛇舌草6重量份、半枝莲5重量份、地丁2重量份、朱砂根6重量份、连翘6重量份、岗梅根4重量份、金盏银盘6重量份、贯叶连翘6重量份、珍珠草5重量份、茶叶6重量份、穿心莲6重量份、桦木皮8重量份、鸭跖草6重量份、射干2重量份、拳参1重量份、黄连6重量份、黄花母6重量份、救必应6重量份、象皮木5重量份、橄榄6重量份和甘草9重量份,将以上43味中药放入1800毫升水中,浸泡30分钟,然后文火煎制30分钟,过滤去渣共煎药液390毫升,煎出的药液即为治疗过食熏肉型贲门炎的中药。
该发明的优点是:本方43味中药,在药店均能买到,制作简单,制成的中药液毒副作用小,疗程短,治愈率高。君臣佐使,恰到好处。应用中药的同时,避免了西药磺胺药、抗菌素引起的不良反应、过敏反应和毒性反应。三白草、大青叶、大金钱草、山白菊、山海螺、千里光、千金藤、小飞扬草、马尾连、马桑叶、马鞭草、天荞麦根、无花果、木槿皮、五色梅、牛西西、毛冬青、凤眼草、石蒜、田螺、白薇、白头翁、白花蛇舌草、半枝莲、地丁、朱砂根、连翘、岗梅根,以上28味药具有清热解毒,利尿消肿,凉血止血,利水通淋,理气止痛之功效。在治疗过食熏肉型贲门炎的过程中,起主要治疗作用,故为君药。金盏银盘、贯叶连翘、珍珠草、茶叶、穿心莲、桦木皮、鸭跖草、射干、拳参、黄连、黄花母、救必应、象皮木,以上13味药具有利尿消肿、祛湿除痹、健脾止泻、清热利水清肿、解毒排脓、行水消胀、清热利胆、祛湿退黄、杀虫止痒、降火利尿、清心除烦之功效。在治疗过食熏肉型贲门炎的过程中,能辅助主药发挥治疗作用,故为臣药。橄榄:甘、涩、酸,平。入肺、胃二经。清肺止咳,清热解毒利咽,生津止渴,解毒止痢,平肝镇惊,解鳖毒。能率诸药直达病灶,故为佐药。甘草:甘,平。入十二经。补脾润肺,益气复脉,缓急止痛,清热解毒,调和药性。既能纠诸药之偏性,又能缓解诸药之毒性,故为使药。三白草、大青叶、大金钱草、山白菊、山海螺、千里光、千金藤、小飞扬草、马尾连、马桑叶、马鞭草、天荞麦根、无花果、木槿皮、五色梅、牛西西、毛冬青、凤眼草、石蒜、田螺、白薇、白头翁、白花蛇舌草、半枝莲、地丁、朱砂根、连翘、岗梅根、金盏银盘、贯叶连翘、珍珠草、茶叶、穿心莲、桦木皮、鸭跖草、射干、拳参、黄连、黄花母、救必应、象皮木、橄榄、甘草,这43味药配伍应用,共同起到清热解毒、利尿通淋、凉血止血,利水消肿、理气止痛、热降火,除烦止渴,生肌敛疮、清心安神,降血压之功效。君臣佐使,配伍得当,是治疗过食熏肉型贲门炎的最佳配方。三白草:甘、辛,寒,有小毒。入肺、脾、胃、大肠四经。清热利湿,利水消肿,解毒疗疮,消积化痞。大青叶:苦,寒。入心、胃二经。清热解毒,凉血消斑。大金钱草:甘、咸,微寒。入肝、胆、肾、膀胱四经。清热利湿,和胃降逆,解毒消肿,祛瘀消肿。山白菊:苦、辛,凉。入肺、肝二经。清热解毒,疏风解表,凉血止血。山海螺:甘、辛,平。入肺、大肠、肝二经。排脓生肌,解毒消肿,祛痰散结,催发乳汁。千里光:苦,寒。入肝、肾二经。清热解毒,清肝明目,祛风燥湿。千金藤:苦,寒。入肺、脾、大肠三经。清热解毒,利尿消肿,祛风活络。小飞扬草:酸、涩、苦,凉。入脾、胃、大肠三经。清热利湿,解毒消肿。马尾连:苦,寒。入心、肝、胆、大肠四经。清热燥湿,清热解毒,凉肝明目,利湿退黄。马桑叶:辛、苦,寒,有毒。入心、肺二经。清热解毒,祛风除湿。马鞭草:苦、辛,寒。入肝、脾二经。清热解毒,活血散瘀,利水消肿,截疟。天荞麦根:酸、苦,寒。入心、肺、脾、肝四经。清热解毒,清肺化痰,活血止痛,健脾消食。无花果:甘、平、酸,寒。入肺、胃、大肠三经。健胃厚肠,清热消肿,通乳。木槿皮:甘、苦,凉。入大肠、肝、脾三经。清热利湿,杀虫止痒,清热解毒。五色梅:苦,寒。入大肠经。解毒消肿,祛风止痒,止血。牛西西:苦、酸,寒。入心、肺、大、小肠四经。清热解毒,活血止血,泻火通便。毛冬青:微苦、甘,平。入肺、肝、大肠三经。清热解毒,活血通络,利水渗湿。凤眼草:苦、涩,寒。入大肠、肝、胃三经。清热燥湿,止血、止带。石蒜:辛、甘,温;有毒。入肺、胃二经。解毒消肿,祛痰平喘,利尿去水,催吐救急。田螺:甘、咸,寒。入肝、脾、胃、膀胱、大肠五经。清热利水,解毒消肿,生津止渴,凉血止血,醒酒。白薇:苦、咸,寒。入肺、胃、肾三经。清热凉血,利尿通淋,解毒疗疮,熄风止惊。白头翁:苦,寒。入大肠、肝、胃三经。清热解毒,凉血散瘀,截疟,清肝明目。白花蛇舌草:苦、甘,寒。入心、肝、脾三经。清热解毒,清热利湿,清热散瘀,治疗小儿疳积。半枝莲:辛、微苦,平。入心、肺、肝、肾四经。清热解毒,止血,散瘀止痛,行气利水。地丁:苦、辛,寒,无毒。入心、肝二经。清热解毒,清热利湿。朱砂根:辛、苦,寒。入肺、脾、胃三经。清热解毒,散瘀止痛。连翘:苦,凉。入心、肝、胆三经。清热解毒,消肿散结,清热利尿,治疗白虫病,经闭,疹子。岗梅根:苦、甘,寒。入肺、肝、大肠三经。清热解毒,跌打损伤,津伤口渴。金盏银盘:苦、甘、淡,平。入肺、大肠、脾、胃四经。疏风清热,清热解毒,活血化瘀,消食化积。贯叶连翘:辛、涩、微苦,平。入肺、大肠、胃三经。清热解毒,收涩止血,祛风利湿,疏利通乳。珍珠草:甘、苦,凉。入肝、肺二经。清热利尿,清热解毒,健脾消疳,平肝明目。茶叶:苦、甘、辛,寒。入心、肺、胃、肠、肝、肾六经。清利头目,除烦止渴,利尿,清热解毒,下气消食,化痰。穿心莲:苦,寒。入心、肺二经。清热解毒,清化湿热,凉血消肿,解蛇毒。桦木皮:苦,寒。入肺、胃二经。清热燥湿,解毒消痈,肺风毒疮,祛痰平喘,染发黑须。鸭跖草:甘,寒。入心、肝、胆、脾、大肠五经。清热解毒,清热利湿,利尿消肿,凉血止血。射干:苦、寒,有毒。入肺、肝二经。解毒利咽,清热化痰,散热消结。拳参:苦,微寒。入心、大肠、膀胱三经。泻热利湿止痢,清热解毒消肿,清热镇惊。黄连:苦、寒。入心、肝、胃、大肠四经。清热燥湿,清热泻火,泻火解毒,除疳安蛔。黄花母:甘、辛、酸、涩,凉,无毒。入心、肝、肺、大肠、小肠五经。辛凉解表,清热利湿,凉血止血,清热解毒。救必应:苦,寒。入肺、肝、大肠三经。清热解毒,清热燥湿,消肿止痛。象皮木:苦、淡,寒。入肺、肝二经。清热解毒,止血消肿。橄榄:甘、涩、酸,平。入肺、胃二经。清肺止咳,清热解毒利咽,生津止渴,解毒止痢,平肝镇惊,解鳖毒。甘草:甘,平。入十二经。补脾润肺,益气复脉,缓急止痛,清热解毒,调和药性。
具体实施方式:
取三白草6g、大青叶5g、大金钱草6g、山白菊3g、山海螺6g、千里光6g、千金藤6g、小飞扬草5g、马尾连6g、马桑叶4g、马鞭草6g、天荞麦根6g、无花果9g、木槿皮6g、五色梅5g、牛西西6g、毛冬青8g、凤眼草6g、石蒜5g、田螺6g、白薇3g、白头翁4g、白花蛇舌草6g、半枝莲5g、地丁2g、朱砂根6g、连翘6g、岗梅根4g、金盏银盘6g、贯叶连翘6g、珍珠草5g、茶叶6g、穿心莲6g、桦木皮8g、鸭跖草6g、射干2g、拳参1g、黄连6g、黄花母6g、救必应6g、象皮木5g、橄榄6g和甘草9g,将以上43味药一起放入1800毫升水中,浸泡30分钟,然后文火煎制30分钟,过滤去渣,煎出的药液即为治疗过食熏肉型贲门炎的中药。共煎药液390毫升,当过食熏肉型贲门炎的病人需要治疗时,使药液温度为35℃,每次130毫升,口服,每日三次, 二日为一疗程,若症状仍存,再服第二疗程,以至痊愈。
379例过食熏肉型贲门炎患者中,男性256例,占67.5%;女性123例,占32.5%。男性多于女性。
表一、379例过食熏肉型贲门炎患者的年龄范围
| 年龄(岁) | 18~20 | 21~30 | 31~40 | 41~55 |
| 例数 | 15 | 229 | 122 | 13 |
| 百分比 | 4% | 60.4% | 32.2% | 3.4% |
表二、379例过食熏肉型贲门炎患者疗效表
| 疗效 | 治愈 | 好转 | 无效 |
| 例数 | 376 | 3 | 无 |
| 百分比 | 99.21% | 0.79% | 无 |
表三、379例过食熏肉型贲门炎患者疗程表
| 治疗天数 | 3~5 | 6~9 | 10~14 | 15~25 |
| 例数 | 12 | 229 | 131 | 7 |
| 百分比 | 3.2% | 60.4% | 34.6% | 1.8% |
表四、379例过食熏肉型贲门炎患者治疗前后情况表
Claims (1)
1. 一种治疗过食熏肉型贲门炎的中药制备方法,其特征是:取三白草6克、大青叶5克、大金钱草6克、山白菊3克、山海螺6克、千里光6克、千金藤6克、小飞扬草5克、马尾连6克、马桑叶4克、马鞭草6克、天荞麦根6克、无花果9克、木槿皮6克、五色梅5克、牛西西6克、毛冬青8克、凤眼草6克、石蒜5克、田螺6克、白薇3克、白头翁4克、白花蛇舌草6克、半枝莲5克、地丁2克、朱砂根6克、连翘6克、岗梅根4克、金盏银盘6克、贯叶连翘6克、珍珠草5克、茶叶6克、穿心莲6克、桦木皮8克、鸭跖草6克、射干2克、拳参1克、黄连6克、黄花母6克、救必应6克、象皮木5克、橄榄6克和甘草9克,将以上43味中药放入1800毫升水中,浸泡30分钟,然后文火煎制30分钟,过滤去渣共煎药液390毫升,煎出的药液即为治疗过食熏肉型贲门炎的中药。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101978498A CN103251748A (zh) | 2013-05-25 | 2013-05-25 | 一种治疗过食熏肉型贲门炎的中药制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101978498A CN103251748A (zh) | 2013-05-25 | 2013-05-25 | 一种治疗过食熏肉型贲门炎的中药制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103251748A true CN103251748A (zh) | 2013-08-21 |
Family
ID=48956181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013101978498A Pending CN103251748A (zh) | 2013-05-25 | 2013-05-25 | 一种治疗过食熏肉型贲门炎的中药制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103251748A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103432405A (zh) * | 2013-08-22 | 2013-12-11 | 王恩乐 | 一种治疗嗜食肥肉型腋下急性化脓性淋巴结炎的中药 |
| CN103432403A (zh) * | 2013-08-22 | 2013-12-11 | 王恩乐 | 一种治疗嗜食大蒜型腋下急性化脓性淋巴结炎的中药 |
| CN103463435A (zh) * | 2013-08-22 | 2013-12-25 | 华秀芹 | 一种治疗过食芥茉型腋下急性化脓性淋巴结炎的中药 |
| CN103463436A (zh) * | 2013-08-22 | 2013-12-25 | 华秀芹 | 一种治疗过食咸鱼型腋下急性化脓性淋巴结炎的中药 |
| CN103463323A (zh) * | 2013-08-22 | 2013-12-25 | 华秀芹 | 一种治疗腋下暴肿型腋下急性化脓性淋巴结炎的中药 |
-
2013
- 2013-05-25 CN CN2013101978498A patent/CN103251748A/zh active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103432405A (zh) * | 2013-08-22 | 2013-12-11 | 王恩乐 | 一种治疗嗜食肥肉型腋下急性化脓性淋巴结炎的中药 |
| CN103432403A (zh) * | 2013-08-22 | 2013-12-11 | 王恩乐 | 一种治疗嗜食大蒜型腋下急性化脓性淋巴结炎的中药 |
| CN103463435A (zh) * | 2013-08-22 | 2013-12-25 | 华秀芹 | 一种治疗过食芥茉型腋下急性化脓性淋巴结炎的中药 |
| CN103463436A (zh) * | 2013-08-22 | 2013-12-25 | 华秀芹 | 一种治疗过食咸鱼型腋下急性化脓性淋巴结炎的中药 |
| CN103463323A (zh) * | 2013-08-22 | 2013-12-25 | 华秀芹 | 一种治疗腋下暴肿型腋下急性化脓性淋巴结炎的中药 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103263584A (zh) | 一种治疗溲赤型贲门炎的中药制备方法 | |
| CN103251809A (zh) | 一种治疗口渴型贲门炎的中药制备方法 | |
| CN103251808A (zh) | 一种治疗嗜食高热食品型贲门炎的中药制备方法 | |
| CN103251810A (zh) | 一种治疗热毒型贲门炎的中药制备方法 | |
| CN103251834A (zh) | 一种治疗嗜食鲜姜型贲门炎的中药制备方法 | |
| CN103230536A (zh) | 一种治疗嗜饮热茶型贲门炎的中药制备方法 | |
| CN103251748A (zh) | 一种治疗过食熏肉型贲门炎的中药制备方法 | |
| CN103251838A (zh) | 一种治疗嗜食辣椒型贲门炎的中药制备方法 | |
| CN103251774A (zh) | 一种治疗嗜食芥茉型贲门炎的中药制备方法 | |
| CN103239599A (zh) | 一种治疗咽痛型贲门炎的中药制备方法 | |
| CN103251780A (zh) | 一种治疗血热型贲门炎的中药制备方法 | |
| CN103251781A (zh) | 一种治疗嗜食大蒜型贲门炎的中药制备方法 | |
| CN103251783A (zh) | 一种治疗发热型贲门炎的中药制备方法 | |
| CN103251807A (zh) | 一种治疗肝郁化火型贲门炎的中药制备方法 | |
| CN103251836A (zh) | 一种治疗嗜食生葱型贲门炎的中药制备方法 | |
| CN103230504A (zh) | 一种治疗进食疼痛型贲门炎的中药制备方法 | |
| CN103239645A (zh) | 一种治疗酗酒型贲门炎的中药制备方法 | |
| CN102366525B (zh) | 一种治疗肝气犯胃型胃炎的中药制备方法 | |
| CN103251749A (zh) | 一种治疗过食肥肉型贲门炎的中药制备方法 | |
| CN102366614B (zh) | 一种治疗寒邪客胃型胃炎的中药的制备方法 | |
| CN103110840A (zh) | 一种治疗咽痛型反流性食管炎的中药制备方法 | |
| CN102366592B (zh) | 一种治疗饮食停滞型胃炎的中药制备方法 | |
| CN103251782A (zh) | 一种治疗吸烟型贲门炎的中药制备方法 | |
| CN103251833A (zh) | 一种治疗失眠型贲门炎的中药制备方法 | |
| CN103285180A (zh) | 一种治疗过食烤羊肉串型贲门炎的中药制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130821 |
